20 completed, 4 unknown, 1 not yet recruiting, 1 terminated. 8 Phase 3, 6 Phase 4, 3 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Not yet recruiting 1, Terminated 1 |
| Phase 4 | 6 | Completed 4, Unknown 2 |
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Acenocoumarol: new trials by email Literature Review of Acenocoumarol trials Research Report on Acenocoumarol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid Syndrome Vitamin K Antagonist - Drug, Anticoagulant Therapy Discontinuation - Antiphospholipid Syndrome, Thrombotic Antiphospholipid Syndrome | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 234 | 2026-12-01 | 2026-10-15 |
| Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events Rivaroxaban 20 MG [Xarelto], Aspirin 300mg, Acenocoumarol Oral Tablet - Venous Thromboembolism, Anticoagulant-induced Bleeding | Phase 2 / Phase 3 | Completed | Instituto Mexicano del Seguro Social | 58 | 2021-01-03 | 2022-08-25 |
| Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care Oral anticoagulant - Atrial Fibrillation | Completed | Bayer | 3739 | 2019-10-01 | 2021-04-26 | |
| Start or STop Anticoagulants Randomised Trial (SoSTART) Apixaban, Rivaroxaban, Edoxaban - Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive | Phase 3 | Completed | University of Edinburgh | 203 | 2018-03-28 | 2022-04-08 |
| Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension Oral anticoagulant treatment - Pulmonary Arterial Hypertension | Completed | Centre Hospitalier Universitaire de Saint Etienne | 203 | 2017-07-05 | 2024-06-04 | |
| Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care acenocoumarol, control - Anticoagulant, Pharmacogenetics | Not applicable | Completed | Universidad San Jorge | 204 | 2017-05-22 | 2021-05-04 |
| Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation Edoxaban, VKA-Based Regimen - Atrial Fibrillation | Phase 3 | Completed | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 632 | 2017-03-21 | 2019-09-23 |
| Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC) Acenocoumarol, Standard of care - Prosthetic Cardiac Valve Thrombosis, Cerebrovascular Accident | Phase 4 | Unknown | Semmelweis University Heart and Vascular Center | 200 | 2016-07-01 | 2017-01-18 |
| Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY) Dabigatran, Acenocoumarol - Cardioembolic Stroke | Unknown | Hospital Mutua de Terrassa | 500 | 2016-06-28 | 2018-03-20 | |
| Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban, Vitamin K antagonist: warfarin, fluindione, acenocoumarol - Atrial Fibrillation | Completed | Assistance Publique - Hôpitaux de Paris | 159 | 2015-02-01 | 2022-03-29 | |
| Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke acetylsalicylic acid, clopidogrel bisulfate and/or warfarin, Apixaban, Rivaroxaban, Dabigatran, alteplase, endovascular - Ischemic Stroke | Unknown | Rabin Medical Center | 90 | 2014-12-01 | 2014-12-05 | |
| INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA) Vitamin K antagonists (acenocoumarol or warfarin) - Atrial Fibrillation and Flutter | Completed | Vivencio Barrios | 1524 | 2014-02-01 | 2014-10-29 | |
| Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD Acetylsalicylic acid, Vitamin K antagonist - Cervical Artery Dissection | Phase 3 | Completed | Stefan Engelter | 194 | 2013-09-01 | 2024-05-21 |
| A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy acenocoumarol, vemurafenib - Malignant Melanoma, Neoplasms | Phase 1 | Completed | Hoffmann-La Roche | 9 | 2013-08-01 | 2016-11-02 |
| Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI aspirin+clopidogrel (Duoplavin) - Aortic Valve Stenosis, Stroke | Phase 4 | Completed | Andres Iñiguez Romo, MD, PhD | 124 | 2013-04-01 | 2019-08-09 |
| Rivaroxaban for Patients With Antiphospholipid Syndrome Rivaroxaban, acenocumarol - Antiphospholipid Syndrome | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 190 | 2013-03-13 | 2018-05-11 |
| Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients Heparin, fondaparinux, vitamin-K antagonists, aspirin - Unsuspected Pulmonary Embolism | Completed | G. d'Annunzio University | 695 | 2012-11-01 | 2019-08-08 | |
| Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver Enoxaparin with acenocoumarol, placebo - Portal Vein Thrombosis | Not applicable | Withdrawn | Institute of Liver and Biliary Sciences, India | 2012-06-01 | 2018-06-06 | |
| Pharmacogenetic Dosage Algorithm for Acenocoumarol Acenocoumarol - Atrial Fibrillation, Venous Thromboses | Completed | Instituto de Investigación Hospital Universitario La Paz | 340 | 2011-10-01 | 2017-01-09 | |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism low molecular weight heparin, vitamin K antagonists - Venous Thromboembolism, Neoplasms | Phase 3 | Terminated | University Medical Center Groningen | 56 | 2010-08-01 | 2014-12-03 |
Showing 20 of 27. Sign in to see all of them.
Atrial Fibrillation (9) · Stroke (4) · Neoplasms (3) · Pulmonary Embolism (3) · Venous Thromboembolism (3) · Venous Thrombosis (3) · Antiphospholipid Syndrome (2) · Ischemic Stroke (2) · Aortic Valve Stenosis (1) · Atrial Flutter (1) · Blood Coagulation Disorders (1) · Cerebral Small Vessel Diseases (1) · Embolic Stroke (1) · Heart Valve Diseases (1) · Hematoma, Subdural (1)
Assistance Publique - Hôpitaux de Paris (2) · Hospital Universitari Vall d'Hebron Research Institute (2) · Andres Iñiguez Romo, MD, PhD (1) · Bayer (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Complejo Hospitalario Xeral-Calde (1) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1) · G. d'Annunzio University (1) · Hoffmann-La Roche (1) · Hospital Mutua de Terrassa (1) · Hospital Universitari de Bellvitge (1) · Institute of Liver and Biliary Sciences, India (1) · Instituto Mexicano del Seguro Social (1) · Instituto de Investigación Hospital Universitario La Paz (1) · Maastricht University (1)
Spain (11) · France (6) · Canada (5) · Germany (5) · Netherlands (5) · Italy (4) · United Kingdom (4) · United States (4) · Hungary (3) · Australia (2) · Denmark (2) · New Zealand (2) · Poland (2) · Austria (1) · Belgium (1)
Alejandro Veres Racamonde, MD (1) · Andres Iniguez Romo, MD;PHD (1) · Antoni Romera, MD (1) · Antonia Sambola, MD Ph (1) · Antonio Carcas, MD, PhD (1) · Bernard Boneu, MD (1) · Cees Vermeer, PhD (1) · Florence Tubach, PhD (1) · Guy Raphaeli, MD (1)
PMID 10591382, PMID 11546885, PMID 12917889, PMID 12968085, PMID 15546539, PMID 16494639, PMID 17221328, PMID 18294998, PMID 18705914, PMID 18815396, PMID 19062079, PMID 19348685, PMID 21504259, PMID 21901239, PMID 22015331, PMID 22435369, PMID 23264523, PMID 23493340, PMID 23683967, PMID 24093846, PMID 25173533, PMID 29663464, PMID 31116676, PMID 32756984, PMID 33249467, PMID 34022170, PMID 34320504, PMID 34487722, PMID 35548439, PMID 35915181, PMID 36168113, PMID 36700520, PMID 37704534, PMID 39910883, PMID 7477192
2016 (3), 2009 (1)